Pages that link to "Item:Q4975623"

The following pages link to A Simple Method for Estimating Interactions Between a Treatment and a Large Number of Covariates (Q4975623):

Displaying 50 items.

• Group Inference in High Dimensions with Applications to Hierarchical Testing (Q66200) (← links)
• A single-index model with multiple-links (Q125829) (← links)
• Adaptive kernel estimation of the baseline function in the Cox model with high-dimensional covariates (Q276984) (← links)
• Subgroup causal effect identification and estimation via matching tree (Q830100) (← links)
• D-learning to estimate optimal individual treatment rules (Q1616327) (← links)
• High-dimensional inference for personalized treatment decision (Q1657878) (← links)
• Data shared Lasso: a novel tool to discover uplift (Q1659082) (← links)
• Ensemble survival tree models to reveal pairwise interactions of variables with time-to-events outcomes in low-dimensional setting (Q1672811) (← links)
• Variable selection for estimating the optimal treatment regimes in the presence of a large number of covariates (Q1728653) (← links)
• A simulation study comparing different statistical approaches for the identification of predictive biomarkers (Q2003678) (← links)
• Data-adaptive efficient estimation strategies for biomarker studies embedded in randomized trials (Q2080742) (← links)
• Generalization error bounds of dynamic treatment regimes in penalized regression-based learning (Q2091828) (← links)
• Subgroup identification and variable selection for treatment decision making (Q2135330) (← links)
• Augmented direct learning for conditional average treatment effect estimation with double robustness (Q2154959) (← links)
• The use of covariates and random effects in evaluating predictive biomarkers under a potential outcome framework (Q2258582) (← links)
• Response transformation and profit decomposition for revenue uplift modeling (Q2286984) (← links)
• Fused comparative intervention scoring for heterogeneity of longitudinal intervention effects (Q2318660) (← links)
• Constructing effective personalized policies using counterfactual inference from biased data sets with many features (Q2425241) (← links)
• A survey of personalized treatment models for pricing strategies in insurance (Q2513621) (← links)
• Statistical inference of heterogeneous treatment effect based on single-index model (Q2674496) (← links)
• New methods for treatment effect calibration, with applications to non-inferiority trials (Q2805173) (← links)
• Using decision lists to construct interpretable and parsimonious treatment regimes (Q2809514) (← links)
• Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree (Q2833472) (← links)
• Recursive partitioning for heterogeneous causal effects (Q2962333) (← links)
• Lasso adjustments of treatment effect estimates in randomized experiments (Q2962335) (← links)
• Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules (Q3119800) (← links)
• Multi-subgroup gene screening using semi-parametric hierarchical mixture models and the optimal discovery procedure: Application to a randomized clinical trial in multiple myeloma (Q3119843) (← links)
• Estimation and Inference of Heterogeneous Treatment Effects using Random Forests (Q4559704) (← links)
• Investigation of age–treatment interaction in the SPACE trial using different statistical approaches (Q5036659) (← links)
• <i>i</i>Fusion: Individualized Fusion Learning (Q5120662) (← links)
• Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes (Q5130612) (← links)
• A Sequential Significance Test for Treatment by Covariate Interactions (Q5155191) (← links)
• Testing interaction between treatment and high‐dimensional covariates in randomized clinical trials (Q5280183) (← links)
• Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces (Q5280185) (← links)
• Greedy outcome weighted tree learning of optimal personalized treatment rules (Q5283293) (← links)
• A Two-Part Framework for Estimating Individualized Treatment Rules From Semicontinuous Outcomes (Q5857108) (← links)
• Estimation and Validation of Ratio-based Conditional Average Treatment Effects Using Observational Data (Q5857113) (← links)
• A Semiparametric Approach to Model Effect Modification (Q5885101) (← links)
• On using electronic health records to improve optimal treatment rules in randomized trials (Q6047744) (← links)
• SMIM: A unified framework of survival sensitivity analysis using multiple imputation and martingale (Q6056150) (← links)
• Assessing mediating effects of high‐dimensional microbiome measurements in dietary intervention studies (Q6064183) (← links)
• Estimating the optimal individualized treatment rule from a cost‐effectiveness perspective (Q6079355) (← links)
• Functional additive models for optimizing individualized treatment rules (Q6079849) (← links)
• Stable Discovery of Interpretable Subgroups via Calibration in Causal Studies (Q6089483) (← links)
• Efficient screening of predictive biomarkers for individual treatment selection (Q6094206) (← links)
• LRBmat: a novel gut microbial interaction and individual heterogeneity inference method for colorectal cancer (Q6136943) (← links)
• A reluctant additive model framework for interpretable nonlinear individualized treatment rules (Q6138648) (← links)
• Flexible inference of optimal individualized treatment strategy in covariate adjusted randomization with multiple covariates (Q6158220) (← links)
• Analysing a built-in advantage in asymmetric darts contests using causal machine learning (Q6170912) (← links)
• Model-Assisted Inference for Covariate-Specific Treatment Effects with High-dimensional Data (Q6185139) (← links)